OPK - オプコ・ヘルス (Opko Health Inc.) オプコ・ヘルス

 OPKのチャート


 OPKの企業情報

symbol OPK
会社名 Opko Health Inc (オプコ・ヘルス)
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種 医薬品   医療関連(Health Care)
概要 事業概要 OPKO Health Inc. is a healthcare company. Its segments include Pharmaceutical Diagnostics and Corporate. Pharmaceutical consists of the pharmaceutical operations in Chile Mexico Ireland Israel and Spain and its pharmaceutical research and development operations. Diagnostics consists of the clinical laboratory operations in Bio-Reference Laboratories (Bio-Reference) and its point-of-care operations. Through Bio-Reference it operates laboratory divisions such as Bio-Reference GenPath (Oncology) GenPath (Women's Health) GeneDx and Laboratorio Bueno Salud. As of December 31 2016 it had one commercial stage pharmaceutical product and several pharmaceutical compounds and technologies in various stages of research and development for a range of indications and conditions including Renal Products Biologics hGH-CTP Factor VII Oxyntomodulin active pharmaceutical ingredients Oligonucleotide Therapeutics NK-1 Program Asthma and chronic obstructive pulmonary disease.   オプコ・ヘルスは、米国のバイオ医薬品および診断法開発会社。ポイントオブケア検査、デベロップメントテスト、分子診断テスト、および独自の医薬品やワクチンなどによる診断、治療、予防法を開発。また、前立腺癌の検査薬を開発するほか、二次副甲状腺機能亢進症を治療するためのビタミンDプロホルモンなど研究開発のための医薬化合物を手掛ける。   Opko Health Inc. is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and novel and proprietary technologies.
本社所在地 4400 Biscayne Blvd. Miami FL 33137 USA
代表者氏名 Phillip Frost フィリップフロスト
代表者役職名 Chairman of the Board Chief Executive Officer 取締役会長兼最高経営責任者
電話番号 +1 305-575-4138
設立年月日 33512
市場名 NYSE(ニューヨーク証券取引所)
ipoyear ―年
従業員数 5936人
url www.opko.com
nasdaq_url https://www.nasdaq.com/symbol/opk
adr_tso
EBITDA EBITDA(百万ドル) -151.44300
終値(lastsale) 3.68
時価総額(marketcap) 2059957261.6
時価総額 時価総額(百万ドル) 29.578
売上高 売上高(百万ドル) 975.79400
企業価値(EV) 企業価値(EV)(百万ドル) 2138.946
当期純利益 当期純利益(百万ドル) -309.66200
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Opko Health Inc. revenues decreased 7% to $518.6M. Net loss decreased 4% to $49.3M. Revenues reflect Diagnostics segment decrease of 12% to $427.4M Pharmaceutical segment decrease of 29% to $56.4M United States segment decrease of 16% to $437.8M Israel segment decrease of 48% to $6.1M Ireland segment decrease of 11% to $38.1M. Lower net loss reflects Pharmaceutical segment loss decrease of 40% to $20.8M.

 OPKのテクニカル分析


 OPKのニュース

   Important Factors to Analyze A Good Investment: OPKO Health, Inc. (NASDAQ:OPK), Great Panther Mining Limited (AMEX:GPL)  2021/06/29 22:55:26 Stock Equity
OPKO Health, Inc. (OPK) with the stream of 3.71% also noticed, India Great Panther Mining Limited (GPL) encountered a rapid change of -3.43% in the last hour of Tuesdays trading The post Important Factors to Analyze A Good Investment: OPKO Health, Inc. (NASDAQ:OPK), Great Panther Mining Limited (AMEX:GPL) appeared first on Stocks Equity .
   Prostate Cancer Diagnostics Market 2021 Overwhelming Extensive Business Opportunities by Maintaining A Strong Outlook Till 2028 | Top Key Players: MDxHealth,3D Signatures,Genomic Health,Abbott,OPKO Health, INC & More  2021/06/28 21:48:00 iCrowdNewswire
The Insight Partners announces the research on Global Prostate Cancer Diagnostics Market as it covers the key boundaries required for your Research Need. This Global Prostate Cancer Diagnostics Market Report []
   Global Clinical Laboratory Tests Market 2021 COVID-19 Impact Analysis, Demand, Growth, Technology Trends, Key Findings And Forecasts By 2028 || Abbott ARUP Laboratories OPKO Health, Inc. Bioscientia Institute for Medical Diagnostics GmbH  2021/06/23 03:23:17 OpenPR
Global Clinical Laboratory Tests Market report is a complete overview of the market that covers various aspects of product definition, market segmentation based on various parameters, and the existing vendor landscape. Company snapshot, geographical presence, product portfolio, and recent developments
   OPKO Health subsidiary partners with Royal Caribbean for COVID-19 testing program  2021/06/22 12:17:20 Seeking Alpha
   OPKO Health Appoints Katherine Stueland as President and CEO of GeneDx  2021/06/22 12:00:00 OPKO Health
MIAMI, June 22, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced the appointment of Katherine Stueland as President
   OPKO Health, Inc. (OPK) CEO Phillip Frost presents at Jefferies 2021 Virtual Healthcare Conference (Transcript)  2021/06/02 20:03:06 Seeking Alpha
   Abbott sinks after slashing 2021 guidance  2021/06/01 14:22:27 Seeking Alpha
   OPKO Health perks up amid insider purchase  2021/05/26 17:38:29 Seeking Alpha
   Price Over Earnings Overview: Heico  2021/05/26 17:26:15 Benzinga
Looking into the current session, Heico Inc. (NYSE: HEI ) is trading at $134.68, after a 0.30% decrease. Over the past month, the stock fell by 4.10%, but over the past year, it actually increased by 29.60%. With questionable short-term performance like this, and great long-term performance, long-term shareholders might want to start looking into the company's price-to-earnings ratio. Assuming that all other factors are held constant, this could present itself as an opportunity for shareholders trying to capitalize on the higher share price. The stock is currently under from its 52 week high by … Full story available on Benzinga.com
   Partner Communications Company Ltd (PTNR) CEO Isaac Benbenisti on Q1 2021 Results - Earnings Call Transcript  2021/05/26 16:07:05 Seeking Alpha
   Clinical Laboratory Tests Market – Analysis and In-depth Research on Forecast 2021-2027 : Abbott, ARUP Laboratories, OPKO Health, Inc., Quest Diagnostics  2021/03/22 17:18:17 OpenPR
The insight Partners Research has recently added a concise research on the Global Clinical Laboratory Tests Market – Industry Trends and Forecast to 2027. A reliable Global Clinical Laboratory Tests Market report contains market data that can be relatively essential
   Mpraeso MP Enrols Constituency Officials In A Three-Day Workshop  2021/02/22 20:35:33 Ghana Guardian
Hon Davis Opoku Ansah (OPK), Member of Parliament for MPraeso, has enrolled some selected constituency, electoral area and polling station officers from the Mpraeso Constituency three-day training at…
   New York State Partners with BioReference Laboratories to Spearhead the NY Forward COVID-19 Rapid Test Program to Help Reopen the New York Economy  2021/02/22 13:38:00 PR Newswire
NEW YORK, Feb. 22, 2021 /PRNewswire/ -- BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), announced its participation in the NY Forward Rapid Testing Program and opened eight locations offering COVID-19 rapid testing around New York. This program is designed to provide…
   OPKO Health shares are trading higher after the company announced it would participate in the New York Forward Rapid Testing Program.  2021/02/22 08:42:00 Benzinga
This headline-only article is meant to show you why a stock is moving, the most difficult aspect of stock trading. Every day we publish hundreds of …
   Opko Health's Q4 Service Revenues More Than Double Due To COVID-19 Testing Services  2021/02/19 11:14:13 Benzinga
Opko Health Inc (NASDAQ: OPK ) reported Q4 results that came in above expectations with EPS of $0.05 beating the estimate of $0.04 and sales of $494.6 million higher than the consensus of $443.1 million. The growth was driven by a more than double increase in service revenues, slightly offset by lower product revenues. Product revenues decreased 4% Y/Y to $30.8 million, while service revenues increased 157% to $457.9 million due to COVID-19 testing volume that was slightly offset by lower clinical test volume. Revenues from licensing and the transfer of intellectual property fell 59% to $5.9 million. Opko posted a $32.3 million net income, a turnaround from a loss of $112.4 million. Revenues for BioReference were up 170% … Full story available on Benzinga.com

 関連キーワード  (医薬品 米国株 オプコ・ヘルス OPK Opko Health Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)